Cross-protective and infection-enhancing immunity in mice vaccinated against flaviviruses belonging to the Japanese encephalitis virus serocomplex

被引:26
作者
Lobigs, M
Pavy, M
Hall, R
机构
[1] Australian Natl Univ, John Curtin Sch Med Res, Div Cell Biol & Immunol, Canberra, ACT 2601, Australia
[2] Univ Queensland, Dept Microbiol & Parasitol, Brisbane, Qld 4072, Australia
基金
英国医学研究理事会;
关键词
flavivirus; immune-enhancement; vaccine;
D O I
10.1016/S0264-410X(02)00743-0
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The Japanese encephalitis virus serocomplex is a group of mosquito-borne flaviviruses that cause severe encephalitic disease in humans. The recent emergence of several members of this serocomplex in geographic regions where other closely related flaviviruses are endemic has raised urgent human health issues. Thus, the impact of vaccination against one of these neurotropic virus on the outcome of infection with a second, serologically related virus is unknown. We show here that immunity against Murray Valley encephalitis virus in vaccinated mice can cross-protect but also augment disease severity following challenge with Japanese encephalitis virus. Immunepotentiation of heterologous flavivirus disease was apparent in animals immunized with a 'killed' virus preparation when humoral antiviral immunty of low magnitude was elicited. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1572 / 1579
页数:8
相关论文
共 55 条
[31]  
HUANG CH, 1963, ACTA VIROL, V7, P322
[32]  
ILKAL MA, 1994, ACTA VIROL, V38, P157
[33]   MICE IMMUNIZED WITH A SUBVIRAL PARTICLE CONTAINING THE JAPANESE ENCEPHALITIS-VIRUS PRM/M AND E-PROTEINS ARE PROTECTED FROM LETHAL JEV INFECTION [J].
KONISHI, E ;
PINCUS, S ;
PAOLETTI, E ;
SHOPE, RE ;
BURRAGE, T ;
MASON, PW .
VIROLOGY, 1992, 188 (02) :714-720
[34]   Generation and characterization of a mammalian cell line continuously expressing Japanese encephalitis virus subviral particles [J].
Konishi, E ;
Fujii, A ;
Mason, PW .
JOURNAL OF VIROLOGY, 2001, 75 (05) :2204-2212
[35]  
LINDENBACH BD, 2001, FIELDS VIROLOGY, V4, P991
[36]   PROTEOLYTIC PROCESSING OF A MURRAY VALLEY ENCEPHALITIS-VIRUS NONSTRUCTURAL POLYPROTEIN SEGMENT CONTAINING THE VIRAL PROTEINASE - ACCUMULATION OF A NS3-4A PRECURSOR WHICH REQUIRES MATURE NS3 FOR EFFICIENT PROCESSING [J].
LOBIGS, M .
JOURNAL OF GENERAL VIROLOGY, 1992, 73 :2305-2312
[37]   GENETIC DIFFERENTIATION OF MURRAY VALLEY ENCEPHALITIS-VIRUS IN AUSTRALIA AND PAPUA-NEW-GUINEA [J].
LOBIGS, M ;
MARSHALL, ID ;
WEIR, RC ;
DALGARNO, L .
AUSTRALIAN JOURNAL OF EXPERIMENTAL BIOLOGY AND MEDICAL SCIENCE, 1986, 64 :571-585
[38]   Lack of both Fas ligand and perforin protects from flavivirus-mediated encephalitis in mice [J].
Luna, RML ;
Lee, E ;
Müllbacher, A ;
Blanden, RV ;
Langman, R ;
Lobigs, M .
JOURNAL OF VIROLOGY, 2002, 76 (07) :3202-3211
[39]   MURRAY VALLEY ENCEPHALITIS INFECTION IN THE LABORATORY MOUSE .1. INFLUENCE OF AGE ON SUSCEPTIBILITY TO INFECTION [J].
MACDONALD, F .
AUSTRALIAN JOURNAL OF EXPERIMENTAL BIOLOGY AND MEDICAL SCIENCE, 1952, 30 (04) :319-324
[40]   Suppression of lipopolysaccharide-induced antiviral transcription factor (STAT-1 and NF-κB) complexes by anti body-dependent enhancement of macrophage infection by Ross River virus [J].
Mahalingam, S ;
Lidbury, BA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (21) :13819-13824